Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Mar 28, 2018 10:13pm
181 Views
Post# 27799646

I give PLI a "B" for good progress and improved performance.

I give PLI a "B" for good progress and improved performance.I think that this was a better Q 4 report than ever before presentd by PLI.  And, you all know how negative I can be.  I would have given PLI an AAA except for the chinese fiasco.  When will PLI learn its lessons on doing deals?  They have a long long track record of failure here.  However, we are now makiing steady progress so that can be written off to experience.

Good news on BioSeparation was:

Total revenues for the year ended December 31, 2017 were $39.1 million compared to $16.4 million for the year ended December 31, 2016.

BoioSeparation is now finally showing its long held, long delayed promise as a business enterprise.  Thankgawd for that one.
.
My Final report card.

PLI:  "B"  for continuing progress
Fluff pumpers.  "D-"  for nasty attempts to mislead and stifle discussion
Bashers:  "A" for insight.





Bullboard Posts